Penn Mutual Asset Management, LLC Vaxcyte, Inc. Transaction History

Penn Mutual Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $338,038 - $444,640	15,585 New	15,585 $374,000
Q2 2021 Aug 26, 2021	SELL	$16.45 - $24.06 $365,634 - $534,781	-22,227 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$18.66 - $29.16 $242,337 - $378,700	12,987 Added 140.55%	22,227 $439,000
Q4 2020 Feb 09, 2021	BUY	$26.57 - $51.74 $245,506 - $478,077	9,240 New	9,240 $246,000

350

132M

577K

310K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.98B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Penn Mutual Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Mutual Asset Management, LLC with notifications on news.